Alison Moorat

572 total citations
6 papers, 420 citations indexed

About

Alison Moorat is a scholar working on Epidemiology, Hepatology and Physiology. According to data from OpenAlex, Alison Moorat has authored 6 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 3 papers in Hepatology and 2 papers in Physiology. Recurrent topics in Alison Moorat's work include Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers) and Asthma and respiratory diseases (2 papers). Alison Moorat is often cited by papers focused on Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers) and Asthma and respiratory diseases (2 papers). Alison Moorat collaborates with scholars based in United Kingdom, Netherlands and Germany. Alison Moorat's co-authors include Carol Brosgart, Bernard Willems, David Mutimer, Hie-Won Hann, Mary Woessner, Robert Perrillo, Eric Bourne, William M. Lee, Stephen D. Gardner and Eugene R. Schiff and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and The Journal of Pediatrics.

In The Last Decade

Alison Moorat

6 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Moorat United Kingdom 5 390 383 69 23 22 6 420
Kyoko Yoshida Japan 5 222 0.6× 205 0.5× 40 0.6× 9 0.4× 48 2.2× 8 282
Peter Bramley United Kingdom 10 325 0.8× 318 0.8× 38 0.6× 28 1.2× 4 0.2× 14 369
C Casalino Italy 5 296 0.8× 315 0.8× 40 0.6× 4 0.2× 5 0.2× 9 349
Milotka Fabri Serbia 6 165 0.4× 163 0.4× 48 0.7× 4 0.2× 5 0.2× 27 223
Jianning Jiang China 7 123 0.3× 94 0.2× 33 0.5× 7 0.3× 11 0.5× 27 170
Mohsen Salama Egypt 7 112 0.3× 101 0.3× 22 0.3× 4 0.2× 8 0.4× 23 180
Jennifer Leong United States 8 123 0.3× 91 0.2× 48 0.7× 5 0.2× 5 0.2× 15 195
Anika Wranke Germany 12 387 1.0× 398 1.0× 26 0.4× 4 0.2× 3 0.1× 20 443
V. de Lédinghen France 7 109 0.3× 105 0.3× 27 0.4× 10 0.4× 6 0.3× 11 175
Kevin R. Frost United States 7 117 0.3× 62 0.2× 187 2.7× 7 0.3× 3 0.1× 9 276

Countries citing papers authored by Alison Moorat

Since Specialization
Citations

This map shows the geographic impact of Alison Moorat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Moorat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Moorat more than expected).

Fields of papers citing papers by Alison Moorat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Moorat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Moorat. The network helps show where Alison Moorat may publish in the future.

Co-authorship network of co-authors of Alison Moorat

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Moorat. A scholar is included among the top collaborators of Alison Moorat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Moorat. Alison Moorat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
D’Antiga, Lorenzo, Marion Aw, Mark Atkins, et al.. (2006). Combined lamivudine/interferon-α treatment in ‘immunotolerant’ children perinatally infected with hepatitis B: A pilot study. The Journal of Pediatrics. 148(2). 228–233.e1. 73 indexed citations
2.
Perrillo, Robert, Hie-Won Hann, David Mutimer, et al.. (2003). Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. Gastroenterology. 126(1). 81–90. 300 indexed citations
3.
Peters, Marion G., Paul Martin, E. Jenny Heathcote, et al.. (2002). Adefovir dipivoxil (ADV) alone and in combination with lamivudine (LAM) suppresses LAM-resistant hepatitis B virus (HBV) replication: 16 week interim analysis. Journal of Hepatology. 36. 6–7. 21 indexed citations
4.
Kerr, Michael, et al.. (1999). Switch to monotherapy with lamictal compared to valproate. ORCA Online Research @Cardiff (Cardiff University). 1 indexed citations
5.
Berg, Andrea von, et al.. (1998). A comparison of regular salmeterol vs ‘as required’ salbutamol therapy in asthmatic children. Respiratory Medicine. 92(2). 292–299. 21 indexed citations
6.
Birchall, Martin, Finbarr O’Connell, Alison Moorat, et al.. (1996). Topical Salmeterol Reduces Protein Content of Nasal Lavage Fluid in Response to Allergen and Histamine Challenge: Double-Blind Cross-over Placebo-Controlled Studies in Adults. American Journal of Rhinology. 10(4). 251–256. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026